美股A股
StockGist

Prestige Consumer Healthcare Inc.

PBHNYSE · Healthcare · Medical - DistributionGARP
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and per…
$46.19+1.92%
报价 2026-11-13
市值
$2.19B
EV
$3.3B
PE (TTM)
12.4x
预期 PE (FY2027)
10.2x
52 周区间距高点 -34.2%
$42.98$70.21

筛选结果

pipeline · 2026-11-13
Keep✗ 高增长✗ Cheap✓ GARP
GARP Pool: growth 10-30%, PE <= 20, EV/EBITDA <= 12, P/FCF <= 20, MC/GP <= 11

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22028-031.2x4.48 → 5.08(1.1x)9.1
FY+32029-031.2x4.48 → 5.34(1.2x)8.6

毛利率 54% · TTM 收入 $1167M · 基数 EPS 4.48(调整后)

电话会信号

辅助标签
Q2 20272026-11-05
下调/撤回指引供不应求
指引 下调
信心 3
分析师 3

“We expect to see the benefits from these acquisitions on long-term growth and value creation.”

原文引用(2)
  • 下调/撤回指引:we are adjusting our fiscal 2027 outlook this morning to reflect production variability
  • 供不应求:with zero safety stock, it has an outsized impact on near-term results

蓝色标签在暴涨研究中略有区分度;悬停查看口径。

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
PBHPrestige Consumer Healthcare Inc.$2.19B+1.9%+16.6%50%12.4x10.0x9.1xGARP
CONConcentra Group Holdings Parent, Inc.$5.38B-1.0%+9.6%31.7%22.9x14.2x13.0x
LIVNLivaNova PLC$5.03B+1.2%+11.1%67.4%25.4x22.7x38.9xGARP
ICUIICU Medical, Inc.$4.48B+1.1%-0.8%36.4%90.1x20.0x52.4x
HTFLHeartflow, Inc. Common Stock$4.26B-19.1%+43.4%83.6%–––高增长
LEGNLegend Biotech Corporation$3.24B-5.6%+39.1%55%–––
PRVAPrivia Health Group, Inc.$3.14B+3.7%+20.0%21%86.2x35.4x28.4x
IRONDisc Medicine, Inc.$3.07B-3.9%-47.5%0%–––
ZLABZai Lab Limited$2.78B-5.5%–56.5%–––
同行中位数––+11.1%45.7%55.8x21.4x33.6x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-03-31
Q4 2026
2025-12-31
Q3 2026
2025-09-30
Q2 2026
2025-06-30
Q1 2026
2025-03-31
Q4 2025
2024-12-31
Q3 2025
2024-09-30
Q2 2025
2024-06-30
Q1 2025
Revenue$281.6M$283.4M$274.1M$249.5M$296.8M$290.3M$283.5M$267.1M
Gross Margin50%55.5%56.2%54.2%59.2%55.5%55.5%54.7%
Operating Margin26.8%29.1%29.1%28.8%29.8%31.7%29.7%27%
Net Income$53.9M$46.7M$42.2M$47.5M$50.1M$61M$54.4M$49.1M
Diluted EPS1.130.970.860.9511.221.090.98
Operating Cash Flow$50.6M$78.3M$57.5M$79M$61.8M$65.1M$69.8M$54.8M

研究材料